Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
$470M |
| 2 |
Pfizer
PFE
|
$258M |
| 3 |
Gilead Sciences
GILD
|
$206M |
| 4 |
Meta Platforms (Facebook)
META
|
$188M |
| 5 |
Comcast
CMCSA
|
$179M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$390M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
$231M |
| 4 |
Amgen
AMGN
|
$230M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$154M |
Sector Composition
| 1 | Technology | 14.42% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.5% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$251B
| $749M | 1.63% | 12,898,800 -272,200 | -2% | -$15.8M |
|
2
Colgate-Palmolive
CL
$67.9B
| $670M | 1.46% | 10,062,900 -1,374,800 | -12% | -$91.6M |
|
|
3
Apple
AAPL
$3.45T
| $470M | 1.02% | +4,463,233 | New | +$470M |
|
4
VeriSign
VRSN
$25.5B
| $426M | 0.93% | 4,876,476 -137,600 | -3% | -$12M |
|
5
Alaska Air
ALK
$7.24B
| $386M | 0.84% | 4,799,500 -715,221 | -13% | -$57.6M |
|
6
NetEase
NTES
$86.2B
| $362M | 0.79% | 1,996,100 -589,200 | -23% | -$107M |
|
|
LLTC
7
DELISTED
Linear Technology Corp
LLTC
| $326M | 0.71% | 7,681,200 +19,000 | +0.2% | +$807K |
|
8
Ryanair
RYAAY
$33.7B
| $308M | 0.67% | 3,564,719 +226,089 | +7% | +$19.5M |
|
9
Mastercard
MA
$538B
| $294M | 0.64% | 3,021,400 +205,800 | +7% | +$20M |
|
10
Domino's
DPZ
$15.6B
| $294M | 0.64% | 2,639,900 -180,500 | -6% | -$20.1M |
|
11
Cboe Global Markets
CBOE
$24.7B
| $286M | 0.62% | 4,399,700 +176,000 | +4% | +$11.4M |
|
12
Novartis
NVS
$245B
| $266M | 0.58% | 3,091,198 +1,408,800 | +84% | +$121M |
|
|
13
Pfizer
PFE
$141B
| $258M | 0.56% | +7,985,341 | New | +$258M |
|
14
Palo Alto Networks
PANW
$127B
| $239M | 0.52% | 1,357,000 +726,900 | +115% | +$128M |
|
|
15
Gilead Sciences
GILD
$140B
| $235M | 0.51% | 2,319,448 +2,039,148 | +727% | +$206M |
|
16
Duke Energy
DUK
$95.3B
| $229M | 0.5% | 3,208,267 +143,800 | +5% | +$10.3M |
|
17
Coca-Cola
KO
$297B
| $217M | 0.47% | 5,049,399 +1,753,300 | +53% | +$75.3M |
|
18
Allegiant Air
ALGT
$1.15B
| $212M | 0.46% | 1,263,100 +11,900 | +1% | +$2M |
|
19
AvalonBay Communities
AVB
$27.9B
| $210M | 0.46% | 1,138,514 +278,100 | +32% | +$51.2M |
|
|
BCR
20
DELISTED
CR Bard Inc.
BCR
| $208M | 0.45% | 1,098,500 +207,600 | +23% | +$39.3M |
|
21
Hershey
HSY
$37.3B
| $198M | 0.43% | 2,216,300 -299,100 | -12% | -$26.7M |
|
|
B
22
Barrick Mining Corporation
B
$45.4B
| $190M | 0.41% | 25,706,526 +7,613,624 | +42% | +$56.2M |
|
23
Huntington Ingalls Industries
HII
$10.6B
| $189M | 0.41% | 1,488,700 +14,800 | +1% | +$1.88M |
|
|
24
Meta Platforms (Facebook)
META
$1.86T
| $188M | 0.41% | +1,792,200 | New | +$188M |
|
25
Clorox
CLX
$14.5B
| $187M | 0.41% | 1,473,800 -355,100 | -19% | -$45M |
|